HIGH RATES OF NON-RELAPSE MORTALITY AND GRAFT-VERSUS-HOST DISEASE IN PATIENT UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION (ASCT) FOLLOWING NON-MYELOABLATIVE (NMA) CONDITIONING WITH TLI/ATG

被引:0
|
作者
Kanate, A. S. [1 ]
Chaudhary, L. [1 ]
Cumpston, A. [1 ]
Leadmon, S. [1 ]
Bunner, P. [1 ]
Bulian, D. [1 ]
Gibson, L. [1 ]
Tse, W. [1 ]
Abraham, J. [1 ]
Remick, S. [1 ]
Craig, M. [1 ]
Hamadani, M. [1 ]
机构
[1] W Virginia Univ, Morgantown, WV 26506 USA
关键词
D O I
10.1016/j.bbmt.2010.12.476
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
440
引用
收藏
页码:S313 / S313
页数:1
相关论文
共 50 条
  • [1] Oral chronic graft-versus-host disease following allogeneic conventional myeloablative versus non-myeloablative stem cell transplantation
    Demarosi, F
    Soligo, D
    Carrassi, A
    Deliliers, GL
    Manusè, I
    Minazzi, C
    Sardella, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S149 - S149
  • [2] Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas
    Othman, Tamer
    Moskoff, Benjamin N.
    Esteghamat, Naseem
    Hoeg, Rasmus T.
    Rosenberg, Aaron S.
    Jonas, Brian A.
    Abedi, Mehrdad
    Richman, Carol
    Tuscano, Joseph M.
    LEUKEMIA & LYMPHOMA, 2022, 63 (01) : 231 - 234
  • [3] INCIDENCE OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS WITH ALLOGENEIC PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER A NON-MYELOABLATIVE CONDITIONING
    Cantu, O.
    Gutierrez, H.
    Ruiz, G.
    Lopez, A.
    Mancias, C.
    Martinez, S.
    Gonzalez, O.
    Jaime, J.
    Gomez, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 653 - 653
  • [4] INCIDENCE OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS WITH ALLOGENEIC PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER A NON-MYELOABLATIVE CONDITIONING
    Cantu, O. G.
    Gutierrez, H.
    Ruiz, G.
    Mancias, C.
    Martinez, S. A.
    Gonzalez, O.
    Jaime, J. C.
    Gomez, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S314 - S314
  • [5] Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation
    Kekre, Natasha
    Kim, Haesook T.
    Ho, Vincent T.
    Cutler, Corey
    Armand, Philippe
    Nikiforow, Sarah
    Alyea, Edwin P.
    Soiffer, Robert J.
    Antin, Joseph H.
    Connors, Jean M.
    Koreth, John
    HAEMATOLOGICA, 2017, 102 (07) : 1185 - 1191
  • [6] Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation
    Mattsson, J
    Uzunel, M
    Brune, M
    Hentschke, P
    Barkholt, L
    Stierner, U
    Aschan, J
    Ringdén, O
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (04) : 935 - 944
  • [7] Impact of Chronic Graft-Versus-Host Disease on Non-Relapse Mortality
    Jiang, Justin
    Zhao, Qiuhong
    Sigmund, Audrey M.
    Elder, Patrick
    Benson, Don M., Jr.
    Rosko, Ashley
    Chaudhry, Maria
    Bumma, Naresh
    Khan, Abdullah
    Devarakonda, Srinivas
    Vasu, Sumithira
    Jaglowski, Samantha
    William, Basem M.
    Mims, Alice S.
    Choe, Hannah
    Larkin, Karilyn
    Brammer, Jonathan E.
    Wall, Sarah A.
    Grieselhuber, Nicole
    Saad, Ayman
    Penza, Sam
    Efebera, Yvonne A.
    Sharma, Nidhi
    BLOOD, 2020, 136
  • [8] Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?
    Y Loh
    Y Oyama
    L Statkute
    L Verda
    K Quigley
    K Yaung
    W Barr
    B Jovanovic
    R K Burt
    Bone Marrow Transplantation, 2007, 39 : 435 - 437
  • [9] Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?
    Loh, Y.
    Oyama, Y.
    Statkute, L.
    Verda, L.
    Quigley, K.
    Yaung, K.
    Barr, W.
    Jovanovic, B.
    Burt, R. K.
    BONE MARROW TRANSPLANTATION, 2007, 39 (07) : 435 - 437
  • [10] A comparison of non-myeloablative versus reduced conditioning for allogeneic stem cell transplantation
    Ringdén, O
    Le Blanc, K
    Uzunel, M
    Mattsson, J
    Barkholt, L
    Remberger, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S38 - S38